These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24592986)

  • 1. Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls.
    Snyder ML; Shields KJ; Korytkowski MT; Sutton-Tyrrell K; Talbott EO
    Gynecol Endocrinol; 2014 Jul; 30(7):511-5. PubMed ID: 24592986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification.
    Osibogun O; Ogunmoroti O; Kolade OB; Hays AG; Okunrintemi V; Minhas AS; Gulati M; Michos ED
    J Womens Health (Larchmt); 2022 Jun; 31(6):762-771. PubMed ID: 35575750
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study.
    Calderon-Margalit R; Siscovick D; Merkin SS; Wang E; Daviglus ML; Schreiner PJ; Sternfeld B; Williams OD; Lewis CE; Azziz R; Schwartz SM; Wellons MF
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2688-94. PubMed ID: 25359859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
    Talbott EO; Zborowski J; Rager J; Stragand JR
    Vasc Health Risk Manag; 2008; 4(2):453-62. PubMed ID: 18561521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement proteins and arterial calcification in middle aged women: Cross-sectional effect of cardiovascular fat. The SWAN Cardiovascular Fat Ancillary Study.
    Nagaraj N; Matthews KA; Shields KJ; Barinas-Mitchell E; Budoff MJ; El Khoudary SR
    Atherosclerosis; 2015 Dec; 243(2):533-9. PubMed ID: 26523990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.
    Christian RC; Dumesic DA; Behrenbeck T; Oberg AL; Sheedy PF; Fitzpatrick LA
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2562-8. PubMed ID: 12788855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.
    Talbott EO; Zborowski JV; Rager JR; Boudreaux MY; Edmundowicz DA; Guzick DS
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5454-61. PubMed ID: 15531497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
    Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
    Shroff R; Kerchner A; Maifeld M; Van Beek EJ; Jagasia D; Dokras A
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4609-14. PubMed ID: 17848406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndrome.
    Yang S; Li Q; Song Y; Tian B; Cheng Q; Qing H; Zhong L; Xia W
    Fertil Steril; 2011 Apr; 95(5):1749-53. PubMed ID: 21316661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.
    Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K
    Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
    Gursoy Calan O; Calan M; Yesil Senses P; Unal Kocabas G; Ozden E; Sari KR; Kocar M; Imamoglu C; Senses YM; Bozkaya G; Bilgir O
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):910-917. PubMed ID: 27434652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
    Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
    Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study.
    Chang AY; Oshiro J; Ayers C; Auchus RJ
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):92-9. PubMed ID: 26608823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 19. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
    Karadağ C; Yoldemir T
    J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
    Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
    J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.